Shop
BIHOCL™ PureCleanse™
Product Description
BIHOCL™ PureCleanse™ offers a safe and non-cytotoxic, yet powerful antimicrobial cleansing solution for wounds, skin, and burns.
With no contraindications for use, hypochlorous acid solutions do not damage healthy cells and tissue as they cleanse and debride the wound bed in preparation for healing. 1-4
As a pure hypochlorous solution, BIHOCL PureCleanse is indicated for the treatment of stage I-IV pressure ulcers, venous insufficiency ulcers, diabetic ulcers, post-surgical wounds, first and second degree burns and minor abrasions.5
A note from the Biomiq team:
PureCleanse has a new look! For a short time, customers may continue to receive select products in their existing packaging while our inventory changes over to the updated packaging. Thank you for your patience, and for choosing PureCleanse.
BENEFITS
INDICATIONS
Under the supervision of health care professionals, BIHOCL™ PureCleanse™ is indicated for the cleansing, irrigating, moistening, debridement and removal of foreign material including microorganisms and debris from exudating and/or dirty wounds and acute or chronic dermal lesions such as:
- Stage I-IV pressure ulcers
- Stasis ulcers
- Diabetic ulcers
- Post-surgical wounds
- First and second degree burns
- Abrasions
- Minor irritations of the skin
- Ingrown toe nails
- Grafted and donor sites
- Exit sites
BIHOCL™ PureCleanse™ is also intended for the moistening and lubricating of absorbent wound dressings.
INGREDIENTS / FORMULATION
- Water
- Sodium chloride (NaCl)
- Pure hypochlorous acid (HOCl) — 0.033%
BIHOCL™ PureCleanse™ — as with all of our hypochlorous products — contains no buffers, stabilizers, or additives. Just pure, stable hypochlorous acid.
INSTRUCTIONS FOR USE
DOWNLOADS / PRODUCT DOCUMENTATION
Product Description
BIHOCL™ PureCleanse™ offers a safe and non-cytotoxic, yet powerful antimicrobial cleansing solution for wounds, skin, and burns.
With no contraindications for use, hypochlorous acid solutions do not damage healthy cells and tissue as they cleanse and debride the wound bed in preparation for healing. 1-4
As a pure hypochlorous solution, BIHOCL PureCleanse is indicated for the treatment of stage I-IV pressure ulcers, venous insufficiency ulcers, diabetic ulcers, post-surgical wounds, first and second degree burns and minor abrasions.5
A note from the Biomiq team:
PureCleanse has a new look! For a short time, customers may continue to receive select products in their existing packaging while our inventory changes over to the updated packaging. Thank you for your patience, and for choosing PureCleanse.
BENEFITS
INDICATIONS
Under the supervision of health care professionals, BIHOCL™ PureCleanse™ is indicated for the cleansing, irrigating, moistening, debridement and removal of foreign material including microorganisms and debris from exudating and/or dirty wounds and acute or chronic dermal lesions such as:
- Stage I-IV pressure ulcers
- Stasis ulcers
- Diabetic ulcers
- Post-surgical wounds
- First and second degree burns
- Abrasions
- Minor irritations of the skin
- Ingrown toe nails
- Grafted and donor sites
- Exit sites
BIHOCL™ PureCleanse™ is also intended for the moistening and lubricating of absorbent wound dressings.
INGREDIENTS / FORMULATION
- Water
- Sodium chloride (NaCl)
- Pure hypochlorous acid (HOCl) — 0.033%
BIHOCL™ PureCleanse™ — as with all of our hypochlorous products — contains no buffers, stabilizers, or additives. Just pure, stable hypochlorous acid.
INSTRUCTIONS FOR USE
DOWNLOADS / PRODUCT DOCUMENTATION
Benefits of HOCl
BIHOCL hypochlorous is in a league of its own. Our formulations are 100% pure, shelf stable for up to two years, and trusted by medical professionals across Canada.
All Natural
Oil Free
Vegan & Organic
Eco-Safe
Alcohol Free
Easy Application
Highly Effective
Additive Free
References
Jenner AM, Ruiz-Rodado E, Dunster C, Halliwell B, Mann GE, Siow RCM. Vitamin C protects against hypochlorous acid–induced glutathione depletion and DNA base and protein damage in human vascular smooth muscle cells. Biochem J. 2007 Feb 1;403(2):433–441.
Winterbourn CC, Brennan SO. Characterization of the oxidation products of the reaction between reduced glutathione and hypochlorous acid. Biochem J. 1997;326(Pt 1):87–92.
Li JX, Pang YZ, Tang CS, Li ZQ. Protective effect of taurine on hypochlorous acid toxicity to nuclear nucleoside triphosphatase in isolated nuclei from rat liver. World J Gastroenterol. 2004;10(5):694–698.
Kearns S, Dawson R Jr. Cytoprotective effect of taurine against hypochlorous acid toxicity to PC12 cells. Adv Exp Med Biol. 2000;483:563–70.
Sterasure Inc. Data on file.
Williams J, Rasmussen E, Robins L, Varela C, Terry D, Harding K (forward). The Handbook of HOCl. 2021.